Clinical Trial Update: Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial sponsored by Northwestern University is evaluating the effects of dapagliflozin on metabolomics and cardiac mechanics in chronic kidn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Northwestern University | Conditions: Chronic Kidney Diseases, Heart Failure With Preserved Ejection Fraction | Phase 1, Phase 2 | Status: RECRUITING